Characteristics of Malignant Pleural Effusion Resident CD8
Aged
Aged, 80 and over
CD8-Positive T-Lymphocytes
/ cytology
Cell Differentiation
Coculture Techniques
/ methods
Female
Gene Expression Regulation, Neoplastic
Humans
Interferon-gamma
/ metabolism
Interleukin-7 Receptor alpha Subunit
/ metabolism
L-Lactate Dehydrogenase
/ metabolism
Lactic Acid
/ metabolism
Leukocyte Common Antigens
/ metabolism
Male
Middle Aged
Myeloid-Derived Suppressor Cells
/ metabolism
Neoplasm Staging
Neoplasms
/ complications
Pleural Effusion, Malignant
/ etiology
Receptors, CCR7
/ metabolism
Tumor Cells, Cultured
T cell response
malignant pleural effusion
metastatic cancer
tumor immunosuppression
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
27 Aug 2020
27 Aug 2020
Historique:
received:
20
07
2020
revised:
19
08
2020
accepted:
25
08
2020
entrez:
2
9
2020
pubmed:
2
9
2020
medline:
23
2
2021
Statut:
epublish
Résumé
While T cell-based cancer immunotherapies have shown great promise, there remains a need to understand how individual metastatic tumor environments impart local T cell dysfunction. At advanced stages, cancers that metastasize to the pleural space can result in a malignant pleural effusion (MPE) that harbors abundant tumor and immune cells, often exceeding 10
Identifiants
pubmed: 32867034
pii: ijms21176178
doi: 10.3390/ijms21176178
pmc: PMC7503595
pii:
doi:
Substances chimiques
CCR7 protein, human
0
IFNG protein, human
0
IL7R protein, human
0
Interleukin-7 Receptor alpha Subunit
0
Receptors, CCR7
0
Lactic Acid
33X04XA5AT
Interferon-gamma
82115-62-6
L-Lactate Dehydrogenase
EC 1.1.1.27
Leukocyte Common Antigens
EC 3.1.3.48
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : R01 CA233521
Pays : United States
Références
Cancer Immunol Immunother. 2018 Aug;67(8):1221-1230
pubmed: 29845338
J Thorac Oncol. 2019 Aug;14(8):1458-1471
pubmed: 31078776
J Thorac Oncol. 2018 Mar;13(3):447-453
pubmed: 29246835
Oncoimmunology. 2019 Jan 22;8(4):e1554969
pubmed: 30906651
PLoS One. 2019 Aug 9;14(8):e0216373
pubmed: 31398192
Int J Cancer. 2016 Nov 15;139(10):2261-9
pubmed: 27459735
Cancer Immunol Res. 2017 Jan;5(1):9-16
pubmed: 27941003
Clin Cancer Res. 2020 Aug 15;26(16):4289-4301
pubmed: 32303540
Trends Immunol. 2019 Apr;40(4):310-327
pubmed: 30890304
Cancer Lett. 2019 Jun 28;452:244-253
pubmed: 30928379
Cancer Res. 2017 Jul 1;77(13):3672-3684
pubmed: 28522749
Blood. 2007 May 1;109(9):3812-9
pubmed: 17255361
BMC Cancer. 2013 Jul 02;13:324
pubmed: 23816056
Cancer Biol Ther. 2005 Mar;4(3):342-6
pubmed: 15846066
Cell. 2015 Sep 10;162(6):1229-41
pubmed: 26321679
J Immunother Cancer. 2019 Apr 18;7(1):110
pubmed: 30999958
Cancer Biomark. 2017 Jul 4;19(4):353-363
pubmed: 28582845
Oncoimmunology. 2018 Jul 23;7(9):e1476816
pubmed: 30228944
Am J Respir Crit Care Med. 2000 Nov;162(5):1987-2001
pubmed: 11069845
J Immunother. 2012 Jun;35(5):400-8
pubmed: 22576345
Clin Cancer Res. 2018 Jun 1;24(11):2473-2481
pubmed: 29386217
Lung Cancer. 2005 Mar;47(3):361-71
pubmed: 15713519
Cancer Sci. 2019 Jul;110(7):2080-2089
pubmed: 31102428
Clin Cancer Res. 2010 Dec 15;16(24):6122-31
pubmed: 20668005
J Immunother. 2007 Jan;30(1):123-9
pubmed: 17198091
J Immunother. 2003 Jul-Aug;26(4):332-42
pubmed: 12843795
J Clin Invest. 2014 May;124(5):2246-59
pubmed: 24667641
Front Immunol. 2016 Feb 16;7:52
pubmed: 26909082
J Clin Invest. 2015 Nov 2;125(11):4212-22
pubmed: 26524592
PLoS Biol. 2015 Jul 16;13(7):e1002202
pubmed: 26181372
Cancer Immunol Immunother. 2017 Jun;66(6):765-776
pubmed: 28289860
J Immunother. 2008 Oct;31(8):742-51
pubmed: 18779745
Cancer Immunol Res. 2016 Sep 2;4(9):734-43
pubmed: 27354337
Scand J Immunol. 2019 Sep;90(3):e12802
pubmed: 31269269
J Immunother Cancer. 2016 Oct 18;4:61
pubmed: 27777771
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
Anticancer Res. 2015 Mar;35(3):1529-35
pubmed: 25750307
Chest. 2002 Oct;122(4):1421-7
pubmed: 12377874
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17071-6
pubmed: 16286658
Trends Immunol. 2016 Mar;37(3):208-220
pubmed: 26858199
Clin Cancer Res. 2004 Apr 15;10(8):2600-8
pubmed: 15102661
Immunology. 2018 Jul;154(3):346-353
pubmed: 29465812
J Thorac Oncol. 2016 Nov;11(11):1993-2005
pubmed: 27544053
Lancet Oncol. 2017 Jun;18(6):792-802
pubmed: 28395880
J Immunol. 2013 Aug 1;191(3):1486-95
pubmed: 23817426
J Immunol. 2005 Mar 1;174(5):2591-601
pubmed: 15728465
PLoS Comput Biol. 2016 Sep 23;12(9):e1005112
pubmed: 27662185